Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation

被引：36

作者：

Montano-Loza, Aldo J. ^{[1
,2
]}

Ronca, Vincenzo ^{[3
,4
,5
]}

Ebadi, Maryam ^{[1
,2
]}

Hansen, Bettina E. ^{[6
]}

Hirschfield, Gideon ^{[6
]}

Elwir, Saleh ^{[7
]}

Alsaed, Mohamad ^{[7
]}

Milkiewicz, Piotr ^{[8
]}

Janik, Maciej K. ^{[8
]}

Marschall, Hanns-Ulrich ^{[9
]}

Burza, Maria Antonella ^{[9
]}

Efe, Cumali ^{[10
]}

Caliskan, Ali Riza ^{[11
]}

Harputluoglu, Murat ^{[11
]}

Kabacam, Gokhan ^{[12
]}

Terrabuio, Debora ^{[13
]}

Onofrio, Fernanda de Quadros ^{[6
]}

Selzner, Nazia ^{[6
]}

Bonder, Alan ^{[14
]}

Pares, Albert ^{[15
]}

Llovet, Laura ^{[15
]}

Akyildiz, Murat ^{[16
,17
]}

Arikan, Cigdem ^{[18
]}

Manns, Michael P. ^{[19
]}

Taubert, Richard ^{[19
]}

Weber, Anna-Lena ^{[19
]}

Schiano, Thomas D. ^{[20
]}

Haydel, Brandy ^{[20
]}

Czubkowski, Piotr ^{[21
]}

Socha, Piotr ^{[21
]}

Oldak, Natalia ^{[21
]}

Akamatsu, Nobuhisa ^{[22
]}

Tanaka, Atsushi ^{[23
]}

Levy, Cynthia ^{[24
]}

Martin, Eric F. ^{[24
]}

Goel, Aparna ^{[25
]}

Sedki, Mai ^{[25
]}

Jankowska, Irena ^{[26
]}

Ikegami, Toru ^{[27
]}

Rodriguez, Maria ^{[28
]}

Sterneck, Martina ^{[28
]}

Weiler-Normann, Christina ^{[28
]}

Schramm, Christoph ^{[28
]}

Donato, Maria Francesca ^{[29
]}

Lohse, Ansgar ^{[30
]}

Andrade, Raul J. ^{[31
,32
]}

Patwardhan, Vilas R. ^{[14
]}

van Hoek, Bart ^{[33
]}

Biewenga, Maaike ^{[33
]}

Kremer, Andreas E. ^{[34
,35
,36
]}

机构：

[1] Univ Alberta, Div Gastroenterol, Edmonton, AB, Canada

[2] Univ Alberta, Liver Unit, Edmonton, AB, Canada

[3] Univ Birmingham, Ctr Liver Res, Birmingham, W Midlands, England

[4] Univ Birmingham, NIHR Birmingham BRC, Birmingham, W Midlands, England

[5] Univ Birmingham, Univ Hosp Birmingham NHS Fdn Trust, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England

[6] Univ Toronto, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[7] Baylor Univ, Med Ctr, Dallas, TX USA

[8] Med Univ Warsaw, Liver & Internal Med Unit, Warsaw, Poland

[9] Sahlgrens Univ Hosp, Gothenburg, Sweden

[10] Harran Univ Hosp, Dept Gastroenterol, Sanliurfa, Turkey

[11] Inonu Univ, Dept Gastroenterol, Sch Med, Malatya, Turkey

[12] Guven Hosp Ankara, Clin Gastroenterol & Liver Transplantat, Ankara, Turkey

[13] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil

[14] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA

[15] Univ Barcelona, Hosp Clin, Liver Unit, CIBERehd,IDIBAPS, Barcelona, Spain

[16] Koc Univ, Dept Gastroenterol, Sch Med, Istanbul, Turkey

[17] Koc Univ, Sch Med, Liver Transplantat Ctr, Istanbul, Turkey

[18] Koc Univ, Sch Med Pediat Gastroenterol & Hepatol, Organ Transplantat Ctr, Koc Univ Res Ctr Translat Med KUTTAM, Istanbul, Turkey

[19] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, European Reference Network Hepatol Dis ERN RARE L, Hannover, Germany

[20] Mt Sinai Med Ctr, Div Liver Dis, Recanati Miller Transplantat Inst, New York, NY 10029 USA

[21] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Nutr Disorders & Pedia, Warsaw, Poland

[22] Univ Tokyo, Tokyo, Japan

[23] Teikyo Univ, Sch Med, Dept Med, Tokyo, Japan

[24] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[25] Stanford Univ, Stanford, CA 94305 USA

[26] Childrens Mem Hlth Inst, Warsaw, Poland

[27] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan

[28] UKE Hamburg, Hamburg, Germany

[29] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Liver Tranplant Hepatol Unit, Div Gastroenterol & Hepatol, Milan, Italy

[30] Univ Med Ctr, Hamburg, Germany

[31] Univ Malaga, Univ Hosp, Gastroenterol Serv IBIMA, Malaga, Spain

[32] Univ Malaga, CIBERehd, Malaga, Spain

[33] Leiden Univ Med Ctr, Leiden, Netherlands

[34] Univ Hosp Erlangen, Dept Med, Erlangen, Germany

[35] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany

[36] Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland

[37] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan

[38] Univ Utah, Salt Lake City, UT USA

[39] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[40] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy

[41] Univ Padua, Padua, Italy

[42] Epatoctr Ticino, Lugano, Switzerland

[43] Univ Svizzera Italiana, Lugano, Switzerland

[44] UPMC Pediat Liver Ctr, Palermo, Italy

[45] IRCCS Bambino Gesu Pediat Hosp, Hepatogastroenterol Nutr & Liver Transplant, Rome, Italy

[46] Henry Ford Hlth Syst, Detroit, MI USA

[47] Univ Paris, Hop Necker, Pediat Liver Unit, French Natl Reference Ctr Rare Dis BA & Genet Cho, Paris, France

[48] Hop Necker Enfants Malad, Gastroenterol Hepatol Nutr Unit, Paris, France

[49] Kings Coll Hosp NHS Fdn Trust, London, England

[50] Univ Birmingham, Ctr Liver & Gastro Res, Birmingham, W Midlands, England

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷 / 01期

基金：

加拿大健康研究院;

关键词：

autoimmune liver disease; recurrent disease; survival; graft survival; liver transplantation; PRIMARY BILIARY-CIRRHOSIS; CYCLOSPORINE; SURVIVAL; DISEASE; DIAGNOSIS; MODEL;

D O I：

10.1016/j.jhep.2022.01.022

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background & Aims: Autoimmune hepatitis can recur after liver transplantation (LT), though the impact of recurrence on patient and graft survival has not been well characterized. We evaluated a large, international, multicenter cohort to identify the probability and risk factors associated with recurrent AIH and the association between recurrent disease and patient and graft survival. Methods: We included 736 patients (77% female, mean age 42 +/- 1 years) with AIH who underwent LT from January 1987 through June 2020, among 33 centers in North America, South America, Europe and Asia. Clinical data before and after LT, biochemical data within the first 12 months after LT, and immunosuppression after LT were analyzed to identify patients at higher risk of AIH recurrence based on histological diagnosis. Results: AIH recurred in 20% of patients after 5 years and 31% after 10 years. Age at LT <= 42 years (hazard ratio [HR] 3.15; 95% CI 1.22-8.16; p = 0.02), use of mycophenolate mofetil post-LT (HR 3.06; 95% CI 1.39-6.73; p = 0.005), donor and recipient sex mismatch (HR 2.57; 95% CI 1.39-4.76; p = 0.003) and high IgG pre-LT (HR 1.04; 95% CI 1.01-1.06; p = 0.004) were associated with higher risk of AIH recurrence after adjusting for other confounders. In multivariate Cox regression, recurrent AIH (as a time-dependent covariate) was significantly associated with graft loss (HR 10.79, 95% CI 5.37-21.66, p <0.001) and death (HR 2.53, 95% CI 1.48-4.33, p = 0.001). Conclusion: Recurrence of AIH following transplant is frequent and is associated with younger age at LT, use of mycophenolate mofetil post-LT, sex mismatch and high IgG pre-LT. We demonstrate an association between disease recurrence and impaired graft and overall survival in patients with AIH, highlighting the importance of ongoing efforts to better characterize, prevent and treat recurrent AIH. Lay summary: Recurrent autoimmune hepatitis following liver transplant is frequent and is associated with some recipient features and the type of immunosuppressive medications use. Recurrent autoimmune hepatitis negatively affects outcomes after liver transplantation. Thus, improved measures are required to prevent and treat this condition. (C) 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

引用

页码：84 / 97

页数：15

共 50 条

[31] Primary Liver Transplantation for Autoimmune Hepatitis: A Comparative Analysis of the European Liver Transplant Registry
Schramm, Christoph
Bubenheim, Michael
Adam, Rene
Karam, Vincent
Buckels, John
O'Grady, John G.
Jamieson, Neville
Pollard, Stephen
Neuhaus, Peter
Manns, Michael M.
Porte, Robert
Castaing, Denis
Paul, Andreas
Traynor, Oscar
Garden, James
Friman, Styrbjorn
Ericzon, Bo-Goran
Fischer, Lutz
Vitko, Stefan
Krawczyk, Marek
Metselaar, Herold J.
Foss, Aksel
Kilic, Murat
Rolles, Keith
Burra, Patrizia
Rogiers, Xavier
Lohse, Ansgar W.
LIVER TRANSPLANTATION, 2010, 16 (04) : 461 - 469
[32] Risk factors for fractures following liver transplantation: a population-based cohort study
Chang, Jei-Wen
Yang, Hui-Hsin
Lin, Niang-Cheng
Kuo, Fang-Cheng
Lin, Tzu-Ching
Tsai, Hsin-Lin
ANNALS OF MEDICINE, 2023, 55 (01)
[33] Possible benefit of splenectomy in liver transplantation for autoimmune hepatitis
Xu, Yan-Tian
Liu, De-Jie
Meng, Fan-Ying
Li, Guang-Bing
Liu, Jun
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2014, 13 (03) : 328 - 331
[34] Spontaneous hemobilia after liver transplantation: Frequency, risk factors, and outcome of endoscopic management
Park, Tae Young
Lee, Sung Koo
Nam, Kwangwoo
Oh, Dongwook
Song, Tae Jun
Park, Do Hyun
Lee, Sang Soo
Seo, Dong-Wan
Kim, Myung-Hwan
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (03) : 583 - 588
[35] De Novo Autoimmune Hepatitis after Liver Transplantation
Guido, Maria
Burra, Patrizia
SEMINARS IN LIVER DISEASE, 2011, 31 (01) : 71 - 81
[36] Multidisciplinary Management of Recurrent Hepatocellular Carcinoma Following Liver Transplantation
Kneuertz, Peter J.
Cosgrove, David P.
Cameron, Andrew M.
Kamel, Ihab R.
Geschwind, Jean-Francois H.
Herman, Joseph M.
Pawlik, Timothy M.
JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (04) : 874 - 881
[37] Hyperdynamic circulation in cirrhosis: predictive factors and outcome following liver transplantation
Siniscalchi, A.
Aurini, L.
Spedicato, S.
Bernardi, E.
Zanoni, A.
Dante, A.
Cimatti, M.
Gamberini, L.
Faenza, S.
MINERVA ANESTESIOLOGICA, 2013, 79 (01) : 15 - 23
[38] Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis
de Boer, Ynto S.
Gerussi, Alessio
van den Brand, Floris F.
Wong, Guan-Wee
Halliday, Neil
Liberal, Rodrigo
Drenth, Joost P. H.
Thorburn, Douglas
Bouma, Gerd
Heneghan, Michael A.
van Gerven, N. M.
Beuers, U.
van Erpecum, K. J.
van Buuren, H. R.
den Ouden, J. W.
Brouwer, J. T.
Vrolijk, J. M.
Verdonk, R. C.
van Hoek, B.
Koek, G. H.
Guichelaar, M. M. J.
Bloemena, E.
van Nieuwkerk, C. M. J.
Schreuder, T. C. M. A.
van der Wouden, E. J.
van Meyel, J. J. M.
Baak, L. C.
Stadhouders, P. H. G. M.
Klemt-Kropp, M.
Verhagen, M. A. M. T.
Bhalla, A.
Kuijvenhoven, J. Ph
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (08) : 1616 - +
[39] Prophylaxis for recurrent hepatitis B virus infection following liver transplantation
Genda, Takuya
HEPATOLOGY RESEARCH, 2013, 43 (01) : 65 - 66
[40] The survival outcomes following liver transplantation (SOFT) score: validation with contemporaneous data and stratification of high-risk cohorts
Rana, Abbas
Jie, Tun
Porubsky, Marian
Habib, Shahid
Rilo, Horacio
Kaplan, Bruce
Gruessner, Angelika
Gruessner, Rainer
CLINICAL TRANSPLANTATION, 2013, 27 (04) : 627 - 632

← 1 2 3 4 5 →